Skip to main content

RKV · Rakovina Therapeutics Inc. · Financials

0.2000 CAD +0.0100 (+5.26%) At close · Nov 6 Intraday price with Plus
Market Cap
4.88M CAD
Shares
24.41M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Net Income
-8.68M -113.1%
FY2025 Net Income FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024
CAD -8.68M -4.07M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.